Literature DB >> 3146428

The effects of tamoxifen on the osteopenia induced by sciatic neurotomy in the rat: a histomorphometric study.

G K Wakley1, B L Baum, K S Hannon, R T Turner.   

Abstract

The effects of a 3-week treatment with the nonsteroidal "antiestrogen" tamoxifen were determined on cortical and trabecular bone mass of the tibiae of growing male rats that had undergone unilateral sciatic neurotomy (USN). USN resulted in decreases in cortical area (-11.3%), cross-sectional area (-8.4%), and periosteal bone formation rate (-32.6%) in cortical bone, indicating that the disuse osteopenia results in a decrease in bone formation in cortical bone. USN significantly reduced the amount of trabecular bone in our metaphyseal sampling site (-75%), markedly increasing the amount of bone surface lined by osteoclasts (+65%) without affecting the surface lined by osteoblasts. These results suggest that trabecular bone disuse osteopenia is due, at least in part, to increased bone resorption. Tamoxifen treatment significantly reduced the loss of trabecular bone, restoring resorbing surface length to the control (sham-operated) animal levels. Tamoxifen treatment of sham-operated animals increased trabecular bone area and surface by 35.7% (+/- 10.5) and 41.8% (+/- 7.8), respectively, and reduced resorbing surface by 21.5% (+/- 11.6) compared with sham-operated placebo-treated rats. Tamoxifen had no significant effect on cortical bone parameters in the sham-operated group. The results indicate that tamoxifen is able to reduce the trabecular bone loss that results from USN, but has no effect on cortical bone disuse osteopenia, or on trabecular bone formation. Moreover, tamoxifen treatment of control (intact) animals inhibited the normal levels of bone resorption occurring in these rapidly growing animals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146428     DOI: 10.1007/bf02553283

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  19 in total

1.  The effects of immobilization on bone histomorphometry in rats.

Authors:  R T Turner; N H Bell
Journal:  J Bone Miner Res       Date:  1986-10       Impact factor: 6.741

2.  Effects of anti-estrogens on bone in castrated and intact female rats.

Authors:  V C Jordan; E Phelps; J U Lindgren
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

3.  Mineral, electrolyte and nitrogen balance studies of the Gemini-VII fourteen-day orbital space flight.

Authors:  L Lutwak; G D Whedon; P A Lachance; J M Reid; H S Lipscomb
Journal:  J Clin Endocrinol Metab       Date:  1969-09       Impact factor: 5.958

4.  Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.

Authors:  R T Turner; G K Wakley; K S Hannon; N H Bell
Journal:  Endocrinology       Date:  1988-03       Impact factor: 4.736

5.  Clomiphene protects against osteoporosis in the mature ovariectomized rat.

Authors:  P T Beall; L K Misra; R L Young; H J Spjut; H J Evans; A LeBlanc
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

6.  Inhibition of rat uterine gland genesis by tamoxifen.

Authors:  W S Branham; D M Sheehan; D R Zehr; K L Medlock; C J Nelson; E Ridlon
Journal:  Endocrinology       Date:  1985-11       Impact factor: 4.736

7.  Metabolism of tamoxifen and its uterotrophic activity.

Authors:  S D Lyman; V C Jordan
Journal:  Biochem Pharmacol       Date:  1985-08-01       Impact factor: 5.858

8.  Skeletal alterations in ovariectomized rats.

Authors:  T J Wronski; P L Lowry; C C Walsh; L A Ignaszewski
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

9.  Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats.

Authors:  R T Turner; G K Wakley; K S Hannon; N H Bell
Journal:  J Bone Miner Res       Date:  1987-10       Impact factor: 6.741

10.  Effects of the antiestrogens tamoxifen and clomiphene on bone resorption in vitro.

Authors:  P J Stewart; P H Stern
Journal:  Endocrinology       Date:  1986-01       Impact factor: 4.736

View more
  7 in total

Review 1.  Management of menopause when estrogen cannot be used.

Authors:  R L Young; N S Kumar; J W Goldzieher
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  Local bone turnover in the metaphysis of the proximal tibia and the lumbar vertebra during the early periods after ovariectomy in rats.

Authors:  M Yamaura; T Nakamura; H Tsurukami; A Hijioka; K Narusawa; H Ohnishi; T Ohta; K Hosoda
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

3.  Ineffectiveness of calcitonin on a local-disuse osteoporosis in the sheep: a histomorphometric study.

Authors:  T Thomas; T M Skerry; L Vico; F Caulin; L E Lanyon; C Alexandre
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

4.  Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study.

Authors:  W G Ryan; J Wolter; J D Bagdade
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

Review 5.  RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases.

Authors:  Hisataka Yasuda
Journal:  World J Orthop       Date:  2013-10-18

6.  Mechanical loading-related bone gain is enhanced by tamoxifen but unaffected by fulvestrant in female mice.

Authors:  Toshihiro Sugiyama; Gabriel L Galea; Lance E Lanyon; Joanna S Price
Journal:  Endocrinology       Date:  2010-10-13       Impact factor: 4.736

7.  The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro.

Authors:  Fang Xie; Chun-Fu Wu; Wan-Ping Lai; Xu-Juan Yang; Pik-Yuan Cheung; Xin-Sheng Yao; Ping-Chung Leung; Man-Sau Wong
Journal:  Evid Based Complement Alternat Med       Date:  2005-07-26       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.